Higher mean blood pressure (BP) levels were associated with faster rates of visual field progression in patients with ...

A student at the Carle Illinois College of Medicine created a lab to provide early hands-on experience with microinvasive ...

The following is a summary of “Sodium-glucose cotransporter 2 inhibitors and glaucoma in patients with type 2 diabetes,” ...

The latest announcement is out from Glaukos ( (GKOS) ).

MOUNTAIN VIEW, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and ...

approximately there were 80 million people with glaucoma globally. This demographic shift calls for more significant ...

A study published in the American Journal of Ophthalmology suggests that the use of SGLT2 inhibitors in diabetes is linked to ...

Glaucoma usually happens when extra fluid gradually increases pressure in the eye and causes irreversible damage to the optic ...

A drug used to treat glaucoma holds promise in the fight against various forms of dementia, according to University of ...

SpyGlass Pharma Inc. has developed an intraocular lens (IOL) capable of continuously delivering drugs to eyes for up to three ...

The seven members, each of them internationally recognized, practicing surgeons, will guide Ciliatech on the latest thinking within the field of ophthalmic and glaucoma surgery. Ciliatech will ...

MediPrint® Ophthalmics (MediPrint), a clinical-stage ophthalmic drug delivery company based in San Diego, announced the results of the Company’s Phase 2b clinical trial of LL-BMT1. Employing a novel ...